Impact of mobilization dose on outcome of critically ill patients receiving mechanical ventilation—a target trial emulation using data from the TEAM trial
Einfluss der Mobilisationsdosis auf das Outcome kritisch kranker Patient:innen unter mechanischer Beatmung – Target-Trial-Emulation mit Daten der TEAM-Studie
American Journal of Respiratory and Critical Care Medicine · 01.03.2026 · 212 (3) · 500-510
DOI: 10.1093/ajrccm/aamaf109 ↗Auf einen Blick
Bei 741 intensivpflichtigen, invasiv beatmeten Erwachsenen war eine längere Mobilisationsdauer mit höherer 28-Tage-Mortalität verbunden, wenn nur niedrige Mobilitätsniveaus erreicht wurden. Bei IMS >4 zeigte sich dieser Zusammenhang nicht.
Fragestellung
Welchen Einfluss hat die Mobilisationsdosis auf die 28-Tage-Mortalität von Patient:innen der TEAM-Studie?
Methode
Target-Trial-Emulation des Per-Protokoll-Effekts bei Erwachsenen auf der ICU unter invasiver Beatmung; simulierte Interventionen mit unterschiedlichen Mobilisationsdauern und IMS-Schwellen; g-Formeln mit Basis- und zeitvariierenden Confoundern.
Ergebnisse
741 Patient:innen; Medianalter 62 Jahre (IQR 51–71), 37 % weiblich. Bei Mobilisationszeit ≤20 Minuten und IMS 2 war das RR für Mortalität 1,33 (95 %-KI 1,10–1,63). Bei IMS 4 war das RR 1,13 (95 %-KI 0,96–1,46).
Schlussfolgerung der Autor:innen
Längere Mobilisation bei nur niedrigen IMS-Werten war mit erhöhter 28-Tage-Mortalität assoziiert.
Kernaussagen
- 741 Patient:innen der TEAM-Studie
- RR 1,33 (95 %-KI 1,10–1,63) bei ≤20 Minuten und IMS 2
- Bei IMS >4 kein Anstieg der Mortalität gegenüber dem natürlichen Verlauf
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Respiratory and Critical Care Medicine, online erschienen am 23.01.2026. Verfasst von Ary Serpa Neto und 22 weiteren Autor:innen. Beteiligte Einrichtung: Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive…. Hauptthemen laut MEDLINE: Respiration, Artificial, Critical Illness, Early Ambulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council of Australia.
Themen: Beatmung und Weaning, Mobilisation
Abstract (Originalsprache)
Rationale
Variability in the outcomes of mobilization interventions is expected due to their complexity, and one of the post hoc hypotheses for the findings of the TEAM trial is the impact of “dosage” of mobilization on clinical outcomes.
Objectives
The aim of the present study is to understand the impact of the “dose” of mobilization on 28-day mortality of patients included in the TEAM trial.
Methods
A target trial emulation estimating the per-protocol effect, which is the effect had all patients in the trial adhered to strategies with different “doses” and timing, was used. All patients included in the TEAM trial (adults in the intensive care unit [ICU] who were undergoing invasive mechanical ventilation) were included and the primary outcome was 28-day mortality. Simulated interventions combining different thresholds of duration of mobilization and different thresholds of highest ICU Mobility Scale (IMS) achieved in each day were assessed using g-formulas considering baseline and time-varying confounders. Measurements and Main Results Overall, 741 patients were included, with a median age of 62 (IQR, 51-71) years; 37% were female. Prolonged mobilization time carried worse outcomes when lower levels of mobility were achieved (risk ratio [RR], 1.33 [95% CI, 1.10-1.63] for mobilization time ≤20 minutes and mobility scale of 2). When an IMS >4 was achieved on a given day, prolonged duration of mobilization did not increase mortality compared to natural course (RR, 1.13 [95% CI, 0.96-1.46] for mobilization time ≤20 minutes and IMS of 4).
Conclusions
Prolonged mobilization when only lower IMS levels could be achieved was associated with increased 28-day mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
- Department of Intensive Care, Austin Hospital, Heidelberg, Australia.
- Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia.
- Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.
- Medical Research Institute of New Zealand, Wellington, New Zealand.
- Physiotherapy Team, Te Whatu Ora-Capital, Coast, Wellington, New Zealand.
ORCID-Profile: Rinaldo Bellomo, Belinda J Gabbe, Claire J Tipping
Förderung
- National Health and Medical Research Council of Australia
Zitieren
APA
Serpa Neto, A., Bailey, M., Seller, D., Agli, A., Bellomo, R., Brickell, K., Broadley, T., Buhr, H., Gabbe, B. J., Gould, D. W., Harrold, M., Higgins, A. M., Hurford, S., Iwashyna, T. J., Nichol, A. D., Presneill, J. J., Schaller, S. J., Sivasuthan, J., Tipping, C. J., …, & TEAM Study Investigators and the ANZICS Clinical Trials Group (2026). Impact of mobilization dose on outcome of critically ill patients receiving mechanical ventilation—a target trial emulation using data from the TEAM trial. American Journal of Respiratory and Critical Care Medicine, 212(3), 500-510. https://doi.org/10.1093/ajrccm/aamaf109
Vancouver
Serpa Neto A, Bailey M, Seller D, Agli A, Bellomo R, Brickell K, et al. Impact of mobilization dose on outcome of critically ill patients receiving mechanical ventilation—a target trial emulation using data from the TEAM trial. American Journal of Respiratory and Critical Care Medicine. 2026;212(3):500-510. doi:10.1093/ajrccm/aamaf109
BibTeX
@article{SerpaNeto2026,
author = {Serpa Neto, Ary and Bailey, Michael and Seller, Daniel and Agli, Alicia and Bellomo, Rinaldo and Brickell, Kathy and Broadley, Tessa and Buhr, Heidi and Gabbe, Belinda J and Gould, Doug W and Harrold, Meg and Higgins, Alisa M and Hurford, Sally and Iwashyna, Theodore J and Nichol, Alistair D and Presneill, Jeffrey J and Schaller, Stefan J and Sivasuthan, Janani and Tipping, Claire J and Webb, Steven and Young, Paul J and Hodgson, Carol L and TEAM Study Investigators and the ANZICS Clinical Trials Group, TEAM Study Investigators and the ANZICS Clinical Trials Group},
title = {Impact of mobilization dose on outcome of critically ill patients receiving mechanical ventilation—a target trial emulation using data from the TEAM trial},
journal = {American Journal of Respiratory and Critical Care Medicine},
year = {2026},
volume = {212},
number = {3},
pages = {500--510},
doi = {10.1093/ajrccm/aamaf109}
}
EUVIMED